Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11919888
Neprilysin inhibitors
granted -
US 11919901
Inhibitors of the menin-MLL interaction
granted -
US 11919896
[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof
granted -
US 11912786
Inhibitor of apoptosis protein (IAP) antagonists
granted -
US 11912695
Benzodiazepine derivatives as RSV inhibitors
granted -
US 11905285
Inhibitors of plasma kallikrein and uses thereof
granted -
US 11897845
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
granted -
US 11891389
PGDH inhibitors and methods of making and using
granted -
US 11890281
SHP2 phosphatase inhibitors and methods of making and using the same
granted -
US 11891399
Inhibitors of cancer invasion, attachment, and/or metastasis
granted -
US 11891607
Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
granted -
US 11884656
Pyrrole derivatives as PLK1 inhibitors
granted -
US 11883386
Prolyl hydroxylase inhibitors and methods of use
granted -
US 11884657
PI-kinase inhibitors with anti-infective activity
granted -
US 11883381
ASH1L inhibitors and methods of treatment therewith
granted -
US 11884748
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
granted -
US 11878977
JAK inhibitors containing a 4-membered heterocyclic amide
granted -
US 11872261
Lipoprotein targeting protease inhibitors and uses
granted -
US 11873296
Solid forms of a dual RAF/MEK inhibitor
granted -
US 11873288
Inhibitors for soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH)
granted -
US 11865125
APKC inhibitors and methods of treating a neurodegenerative disease or disorder
granted -
US 11866446
Inhibitors of APOL1 and methods of using same
granted -
US 11865134
Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitors
granted -
US 11866418
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
granted